IDH1的酸化促进了子宫内膜癌的孕激素抵抗
Jingjie Li1, Zuoshu Qin1, Yunqi Li2
1Precision Research Center for Refractory Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|April 6, 2024
概括
对子宫内膜癌的孕激素治疗可能由于耐药性而失败. 这项研究确定了IDH1的p38依赖酸化是驱动这种耐药性的关键机制,提供了一个新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 孕激素治疗是子宫内膜癌的主要治疗方法,但耐药性往往会发展.
- 推动孕激素耐药性的分子机制仍然不完全理解.
研究的目的:
- 阐明子宫内膜癌中孕激素耐药性的分子基础.
- 确定潜在的治疗点,以克服孕激素耐药性.
主要方法:
- 研究了孕激素对IDH1酸化及其亚细胞局部化的作用.
- 研究了化IDH1 (pT77-IDH1) 和OCT6.6之间的相互作用.
- 评估了IDH1产生的α-甲酸盐 (αKG) 在基因转录中的作用.
- 在体内评估了药理上抑制p38和焦点粘附信号的疗效.
主要成果:
- 孕激素治疗诱导了p38依赖的IDH1在Threonine 77 (pT77-IDH1) 的酸化.
- pT77-IDH1转移到核中并与OCT6.6相互作用.
- 源自IDH1的αKG增强了OCT6的活性,促进了焦点粘附相关基因的转录,并赋予了孕激素耐药性.
- 抑制p38或焦点粘附通路使癌细胞对孕激素治疗敏感.
结论:
- 依赖p38的pT77-IDH1是子宫内膜癌中孕激素耐药性的关键调解者.
- 准p38或焦点粘附信号可能会提高孕激素治疗的疗效.
更多相关视频
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
IP3/DAG Signaling Pathway
12.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


